Although clinical trial sponsors have felt pressure to digitize recruitment and engagement, that move toward electronic campaigns may be overlooking one of biopharma’s most classic and effective outreach tactics: that of print. Currently, 80% of trials miss enrollment windows—and as sponsors look to diversify their participant pools with historically unrepresented populations, existing enrollment goals stand to get even further out of reach. Amid these trends, printed study materials could be a prime but often missed opportunity for life science companies, experts say.

Not only are posters, brochures, and other tactile assets potentially more accessible among diverse participants such as senior, rural, or socioeconomically disadvantaged communities, but print can also help complement digital outreach as part of omnichannel campaigns for all audiences.  Join Kevin and Todd as they walk through these trends, discussing how a print approach can be balanced with digital strategies for a more comprehensive recruitment and engagement program. You’ll learn:

• How biopharma companies are using print across their pipelines
• Which study populations may be most receptive to printed materials
• Best practices to balance print with digital for well-rounded campaigns
• How to measure and replicate the impact of print across recruitment and engagement